Clinical Trials
208 trialsFeasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
UNC Lineberger Comprehensive Cancer Center
LLETZ-IOLI
Ruhr University of Bochum
Smoking Cessation in Women With Gynecological Conditions
University of Oklahoma
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
MEDIATOR
University of Aarhus
PaCUDAHL-Gé
University Hospital, Lille
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
University Hospital, Geneva
SENTICOL2
Hospices Civils de Lyon
Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities
Gynaecologisch Oncologisch Centrum Zuid
Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women
Kasr El Aini Hospital
HPV-VG1
Ruhr University of Bochum
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
UNC Lineberger Comprehensive Cancer Center
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
Ext-VALHUDES
University of Milano Bicocca
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device
The Cleveland Clinic
Reshaping Postpartum Follow-up
Medstar Health Research Institute
First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)
Universiteit Antwerpen
What is the Optimal Training Model for Cervical Awareness?
Izmir City Hospital
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Long Term Follow-up of HPV Vaccine in HIV (CTN 236)
University of British Columbia
UH3
The Cleveland Clinic
Interferon Alpha Therapy for Cervical CINI and HPV Infection
Mongolian National University of Medical Sciences
Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania
University Hospital, Basel, Switzerland
Coughing at Time of Cervical Biopsy
Zydolab - Institute of Cytology and Immune Cytochemistry
QCCA
Peking Union Medical College Hospital
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
V501-213
Merck Sharp & Dohme LLC
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
Universidad Nacional de Colombia
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Inovio Pharmaceuticals
CAPCIN
University Hospital Tuebingen
Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women
Indiana University
DELTA
International Agency for Research on Cancer
ZGynO_CINIII
University Hospital Tuebingen
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Virtual Reality: Influence on Satisfaction, Pain, and Anxiety in Patients Undergoing Colposcopy
Ruhr University of Bochum
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
AIDS Malignancy Consortium
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
Minimally Invasive Benign Hysterectomy
Region Skane
PRESCRIP-TEC
University Medical Center Groningen
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
University of Arkansas
STEP
Kaiser Permanente
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dry Run of the ScreenUrSelf Trial
Universiteit Antwerpen
REVEAL 1
Inovio Pharmaceuticals
Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening
George Washington University
Effectiveness of HPV Vaccine in Thai Adult Women
Mahidol University
Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
Shanghai Zerun Biotechnology Co.,Ltd
Activating Collaborative CIS Support Via Targeted Provider Mailing
Northwestern University
EU-VALHUDES
Hiantis Srl
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Shanghai Zerun Biotechnology Co.,Ltd